Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles.

Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles.
复制标题

DOI:
10.1016/j.tranon.2015.03.011
复制
发表时间:
2015-06
影响因子:
5
通讯作者:
Qi, Xiaoyang
Qi, Xiaoyang
中科院分区:
医学3区
文献类型:
--
作者:
Blanco, Victor M.;Latif, Tahir;Chu, Zhengtao;Qi, Xiaoyang

文献摘要

参考文献

被引文献

相似文献

胰腺癌仍然是最难治性的癌症之一,其预后很差,5年生存率约为6%。由于早期疾病症状不明确,缺乏特异性生物标志物,大约80%的患者出现晚期,无法手术的肿瘤,这是一个艰巨的挑战。尽管进行了许多临床试验,但没有一种化疗药物与客观缓解率超过10%或中位生存期超过5至7个月可靠相关。虽然近年来联合化疗方案提供了一些改善,但总生存期(8-11个月)仍然很差。因此,迫切需要能够改善胰腺癌患者预后的新疗法。在这里,我们总结了目前用于晚期胰腺癌管理的治疗方法,并回顾了针对肿瘤生物标志物的新治疗策略。我们还描述了我们最近使用磷脂酰丝氨酸靶向皂素c偶联二酰基磷脂酰丝氨酸纳米囊泡用于胰腺癌成像和治疗的研究。
Pancreatic cancer remains one of the most intractable cancers, with a dismal prognosis reflected by a 5-year survival of ~ 6%. Since early disease symptoms are undefined and specific biomarkers are lacking, about 80% of patients present with advanced, inoperable tumors that represent a daunting challenge. Despite many clinical trials, no single chemotherapy agent has been reliably associated with objective response rates above 10% or median survival longer than 5 to 7 months. Although combination chemotherapy regimens have in recent years provided some improvement, overall survival (8-11 months) remains very poor. There is therefore a critical need for novel therapies that can improve outcomes for pancreatic cancer patients. Here, we present a summary of the current therapies used in the management of advanced pancreatic cancer and review novel therapeutic strategies that target tumor biomarkers. We also describe our recent research using phosphatidylserine-targeted saposin C–coupled dioleoylphosphatidylserine nanovesicles for imaging and therapy of pancreatic cancer.
DOI: 10.1158/2159-8290.cd-11-0347
发表时间: 2012-08
期刊: Cancer discovery
影响因子: 28.2
作者:
Collisson EA;Trejo CL;Silva JM;Gu S;Korkola JE;Heiser LM;Charles RP;Rabinovich BA;Hann B;Dankort D;Spellman PT;Phillips WA;Gray JW;McMahon M
通讯作者: McMahon M
DOI: 10.1002/cncr.10323.abs
发表时间: 2002-02-15
期刊: CANCER
影响因子: 6.2
作者:
Colucci, G;Giuliani, F;Lopez, M
通讯作者: Lopez, M
DOI: 10.1371/journal.pone.0075507
发表时间: 2013-10-04
期刊: PLOS ONE
影响因子: 3.7
作者:
Chu, Zhengtao;Abu-Baker, Shadi;Qi, Xiaoyang
通讯作者: Qi, Xiaoyang
DOI: 10.1053/j.gastro.2013.01.020
发表时间: 2013-05-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Cappello, Paola;Rolla, Simona;Novelli, Francesco
通讯作者: Novelli, Francesco
DOI: 10.1158/0008-5472.can-09-0015
发表时间: 2009-04-15
期刊: Cancer research
影响因子: 11.2
作者:
Blackford A;Parmigiani G;Kensler TW;Wolfgang C;Jones S;Zhang X;Parsons DW;Lin JC;Leary RJ;Eshleman JR;Goggins M;Jaffee EM;Iacobuzio-Donahue CA;Maitra A;Klein A;Cameron JL;Olino K;Schulick R;Winter J;Vogelstein B;Velculescu VE;Kinzler KW;Hruban RH
通讯作者: Hruban RH